[FATE] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
02-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -6.36%
YoY- -76.59%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 7,558 5,465 2,515 2,802 2,429 2,817 2,632 101.64%
PBT -58,684 -28,072 -33,520 -28,302 -26,609 -23,478 -19,760 106.20%
Tax 0 635 0 691 910 1,015 1,091 -
NP -58,684 -28,072 -33,520 -28,302 -26,609 -23,478 -19,760 106.20%
Tax Rate - - - - - - - -
Total Cost 66,242 33,537 36,035 31,104 29,038 26,295 22,392 105.66%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -776.45 -513.67 -1,332.80 -1,010.06 -1,095.47 -833.44 -750.76 2.26%
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -0.68 -0.35 -0.44 -0.37 -0.40 -0.36 -0.30 72.29%
EPS Diluted -0.68 -0.35 -0.44 -0.37 -0.40 -0.36 -0.30 72.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.